Open Clinical Trials:
CLINICAL TRIAL 21117
A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ALLO-316 Following ALLO-647 Containing Conditioning Regimen in Subjects with Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
Disease Site: Kidney
View Trial DetailsCLINICAL TRIAL 21755
A phase II study of lenvatinib plus everolimus versus cabozantinib in patients with metastatic renal cell carcinoma that progressed on a PD-1/PD-L1 checkpoint inhibitor (LenCabo)
Disease Site: Kidney
View Trial DetailsCLINICAL TRIAL 22321
Disparities in Uptake of New FDA-Approved Therapies for Metastatic Renal Cell Carcinoma
Disease Site: Kidney
View Trial Details